
Iomart chief executive Lucy Dimes in sudden departure
Chairman Richard Last is taking over as executive chair with immediate effect while the board makes arrangements to appoint a new chief executive. He will be supported by chief financial officer Scott Cunningham, Atech chief executive Ryan Langley and Angus MacSween, the founder and a non-executive director of Iomart.
Lucy Dimes (Image: Iomart)
In a brief statement to the London Stock Exchange the company said its board of directors "would like to thank Lucy for all her work in helping to reposition Iomart's business to more fully address the opportunities in the public and private cloud and security markets".
In February Iomart warned that users of its higher-margin private managed services are being replaced at a faster rate than expected by lower-margin cloud and security business. Ms Dimes had prioritised cloud and security business because although this market is less profitable, it offers bigger growth potential.
Iomart said at that time that the acceleration in its customer churn rate would result in profits for the year to March 31 coming in roughly 10% below previous market expectations.
In a subsequent trading update on April 23 the company said it anticipates full-year revenue growth of 13% to approximately £143m, including contributions from acquisitions.
Read more:
Iomart stated today that there has been "no material change to trading" since that time. The company is due to report its full-year results in late June.
Ms Dimes joined Iomart as non-executive chair in August 2022, having previously worked in senior executive positions in both listed and private equity-owned companies spanning the telecoms, technology, business services and financial services sectors.
She transitioned to executive chair on a part-time basis in July 2023 and took sole leadership in September of that year following the abrupt departure of previous chief executive Reece Donovan, who had been in the post since September 2020.
Shares in AIM-listed Iomart were trading more than 5% lower today as of late afternoon.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
15 hours ago
- The Guardian
Drugmaker Invidior to abandon London listing amid exodus of companies
The drugmaker Indivior has become the latest company to abandon its listing in London, heaping further pressure on the London Stock Exchange (LSE) to reinvigorate itself. The Virginia-based company, which makes the opioid addiction treatments Sublocade and Suboxone, switched its main stock listing to the US last year, but now plans to cancel the secondary listing it had retained in London. Indivior said on Monday that in making the decision it had considered the liquidity and trading volumes of its shares on the US's Nasdaq exchange compared with the LSE; the location of its shareholders; and the cost and administrative requirements related to the London listing. More than 80% of Indivior's net revenues come from the US, which has been in the grip of an opioid crisis for decades, after a rise in the use of opioid painkillers led to rising addiction rates and a sharp rise in fatal overdoses. David Wheadon, the Indivior chair, said: 'A single primary listing on Nasdaq best reflects the profile of Indivior's business. We appreciate the support received from shareholders for this initiative and look forward to capitalising on the expected benefits of this move, including reductions in cost and complexity.' The London-listed share price fell by 2% to 925.7p on Monday, giving Indivior a market value of £1.2bn. The LSE has been hit by an exodus of companies, such as the Anglo-German travel company Tui, which opted for a sole listing in Frankfurt last year. 'The London Stock Exchange will be upset it is losing another big name,' said Russ Mould, the investment director at AJ Bell. 'It means the pressure is on to attract new names to the market and keep existing ones.' The blow was softened as the LSE welcomed Anglo American's $11bn (£8bn) platinum spin-off Valterra, which became independent from the mining company. Valterra is listed in South Africa and will now have a London listing as well. Anglo retains a 19.9% stake for now but has promised to sell it down over time. Mould said he had expected Indivior to exit London entirely, as its business is focused on the US, where most of its shareholders are based. The company had been listed in London because it was spun off in 2014 from the UK consumer goods group Reckitt Benckiser, itself listed in London. Indivior appointed the pharma veteran Joseph Ciaffoni as chief executive in February, replacing Mark Crossley after warning of a sharp drop in revenues this year. Last year it posted 9% sales growth to almost $1.2bn. This was driven by Sublocade, a prescription medicine that is injected once a month by health professionals to treat addiction to opioid drugs in adults, alongside mental health support. Suboxone is a similar drug but is given as tablets or as a film that dissolves when placed under the tongue. Sublocade's 2025 sales are expected to be flat compared with last year, while Suboxone film faces a 50% slump in sales because of competition from generic drugs, and Indivior will discontinue Perseris, its once-monthly schizophrenia drug. Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion Indivior also said in February it faced 'numerous lawsuits', including an allegation that Suboxone film was 'defectively designed and caused dental injury'. There have also been cases brought by shareholders in the UK and US. Indivior faces a lawsuit from Wirral council, which administers the Merseyside Pension Fund, in London's high court over alleged false marketing of Suboxone. The case was thrown out in 2023; Wirral council appealed, and Indivior said in February it intended to 'vigorously defend' itself. In 2019, the US justice department charged Indivior with fraudulently claiming Suboxone film was better and safer than similar drugs. Its former parent, Reckitt, agreed to pay a $1.4bn fine to settle the case in July 2019, without any admission of wrongdoing, while Indivior said in 2020 that it had 'pleaded guilty to one count of making a false statement relating to healthcare matters in 2012' and that it would make payments to federal and state authorities totalling $600m over seven years. Shaun Thaxter, the former Indivior chief executive, was sentenced to six months in federal prison in 2020 after pleading guilty to his role in a scheme to secure Medicaid coverage for Suboxone film by misleading officials about its dangers to children.


The Herald Scotland
18 hours ago
- The Herald Scotland
What is the seven year rule in Inheritance Tax for UK?
Not all inheritances happen once you've died. Gifting larger sums of money to loved ones while you're still alive is both a practical and tax-smart way to get money flowing between generations. Some people call this a 'living inheritance', since they're passing on money that would have been inherited – just sooner, rather than later. As long as you're aware of the seven year rule. If you die within seven years of making a substantial gift, the value of the gift will be counted as part of your estate (if not covered by an IHT exemption), and will therefore potentially be liable for IHT if you do not have sufficient nil rate band available on death to protect the gift. These are the essentials you need to know. 1. The seven year gifting rule Two thirds (68%) of UK adults say it's important to them to leave an inheritance, and 65% of retired people plan to pass property or money on. However, changes which will potentially bring more assets into scope for IHT and proposed amendments to the IHT treatment of pensions announced in the Autumn Budget, mean that thousands of taxpayers may find themselves facing a much higher tax bill – and leaving a much lower legacy. As a result, many people are considering gifting money or assets during their lifetime. Under the seven year gifting rule, however, you need to live for seven years from the date of the gift. Otherwise, your beneficiaries may end up returning some of the gift back to HMRC. 2. What counts as a gift? HMRC defines a gift as anything you give away. This includes money, property or land, stocks and shares listed on the London Stock Exchange, household and personal goods, furniture, jewellery or antiques. It also covers unlisted shares if you held them for less than two years before your death. These gifts are called Potentially Exempt Transfers or PETs (unless they fall under an IHT exemption, such as the £3,000 annual exemption). The name sounds more complicated than it actually is. Essentially, your gift is 'potentially exempt' from IHT – an outright gift from one person to another, and you'll only pay IHT on a PET if you do not survive for 7 years from the date of the gift, and the gift is not covered by your available nil rate band on death. A gift over £3,000 could also be considered a Chargeable Lifetime Transfer (CLT). A CLT is most commonly a gift made into a discretionary trust, where you pay the IHT upfront –at 20% on any amount over the Nil Rate Band (currently £325,000 per person). Gifting and IHT can seem complex – it certainly has its fair share of financial jargon. We do strongly advise that you talk to a financial adviser if you're considering a CLT or any kind of Trust, so you can check that it's the right choice for you and your family. Read more: Money HQ | Retirement planning: how to maintain your living standards 3. The 'tapering off' rule The good news is that the rate of IHT on gifts made above the available nil rate band tapers off on a sliding scale. This is known as taper relief; and it ranges from 32% to 8% if you die six years after rule of thumb is, longer you live, the more you'll give. Survive for seven years, and your gift is IHT tax-free. How taper relief works: If you die 3 to 4 years after gifting, the rate of IHT on your gift reduces to 32% If you die 4 to 5 years after gifting, the rate of IHT reduces to 24% If you die 5 to 6 years after gifting, the rate of IHT reduces to 16% If you die 6 to 7 years after gifting, the rate of IHT on your gift to 8%. 4. Can I protect my gift from IHT? If the amount of your gift exceeds you're available nil rate band, you can protect it by taking out a 'gift inter vivos policy'. This is a form of life insurance that protects the recipient from Inheritance Tax (IHT) should you not live for seven years. These policies are designed to mirror the tapering effect of your liability. So that, for example, if you die in year six, it'll pay out the exact amount you'd need. It's a less commonly known insurance, but a financial adviser will be happy to help if you'd like to know more. It is also possible to protect gifts which are made within the available nil rate band using a level term assurance policy, with the term arranged to match the period until the gift falls outside of the estate – this would be 7 years if the gift had just been made. 5. What other gifts can I make tax-free? You can make tax-exempt gifts of up to £3,000 every tax year. Your annual gifting allowance can be split between several people or given in full to one person. When making your first gift, you can roll the gifting allowance from the previous year, so you can gift £6,000. Smaller gifts under £250 are tax free. And any gift to your civil partner or spouse is automatically tax exempt too. Regular gifting each year can steadily reduce the size of your estate, while increasing the financial security and wellbeing of the rest of the family. 6. What's the best age to start making larger gifts? Generosity is good at any age! But building gifting into your long-term plans over several decades means that, statistically, you're less likely to need to worry about the seven year rule. If you're in your early sixties, with children and grandchildren, a substantial gift to help with a house deposit or school fees means you can enjoy seeing the difference it makes while you're still around. Making bigger gifts earlier in your lifetime means you stand a better chance of your gift passing in its entirety to the next generation tax free. 'Gifting between generations keeps money going where it's needed most.' Tony Clark, Senior Propositions Manager, SJP Keeping track of your gifts Keep a written record of each and every gift you make – it could save? your family time, energy and tax. If you can't prove when you made a gift, for example, you may end up paying some IHT whether you like it or not. We're sometimes asked how HMRC actually know what gifts you've made if no record or receipt existed. The short answer is – they don't. However, your executors must sign a legal declaration that all information provided must be full, accurate and truthful when they settle your estate. That includes all gifts made. Keeping a written gifting record, including when you made it, how much it was worth, and who you gave it to will set the record straight. HMRC have a specific form, "IHT403", you can use to record the details of all gifts you make. Planning your gifting In the first chapter of our recent consumer survey, The Real Life Advice Report, over 47% of those in receipt of regular advice said that their adviser had helped them pass money on to loved ones. If you start gifting annual lump sums or regular amounts in good time, you can make a substantial difference to your family's financial wellbeing in the here and now – and their IHT bill in the future. That's an invaluable legacy to leave. Trusts are not regulated by the Financial Conduct Authority. Ben Stark is a chartered financial planner with over a decade of experience advising businesses and families. He is partnered with St. James's Place Wealth Management.


The Herald Scotland
3 days ago
- The Herald Scotland
Uncertainty for savers as Rachel Reeves eyes ISA changes
Recent months have seen intense debate about potential ISA reforms, particularly following Reeves' Spring Statement in March, where she expressed a desire to 'get the balance right between cash and equities to earn better returns for savers, boost the culture of retail investment, and support the growth mission'. The prospect of slashing the cash ISA allowance from £20,000 to as low as £4,000 has sparked alarm, with fears it could penalise cautious savers. On 20 May, the Chancellor confirmed to the BBC that the overall £20,000 ISA allowance would remain intact. Yet, her silence on the specific cash ISA limit within the overall allowance has kept speculation alive, with a potential cut remaining on the table as part of a broader review expected to be launched in July's Mansion House speech. The rationale behind potential reforms is partly rooted in a desire to channel more capital into UK markets. Reeves has been vocal about revitalising the London Stock Exchange, noting that 'hundreds of billions of pounds in cash ISAs' are not being invested productively. This echoes the recent Mansion House Accord, an agreement with the UK's largest workplace pension scheme providers to allocate at least 5% of their default funds to UK private market assets by 2030, which could be followed by further measures aimed at supporting UK public markets too. By potentially nudging cash savers towards stocks and shares ISAs, the government may also hope to address the UK stock market's challenges, including a decline in initial public offerings (IPOs), companies relocating listings overseas where they can command higher valuations and private equity buyouts, factors which have led to a 20% decline in the number of UK listed companies over the last five years. One proposed reform, floated by investment bank Peel Hunt, involves simplifying the ISA system by merging cash and stocks and shares ISAs into a single product and abolishing lifetime ISAs and innovative finance ISAs. Peel Hunt argues that with ISA tax reliefs costing the Treasury an estimated £9.4 billion annually, redirecting these incentives towards UK-focused investments could deliver better value for taxpayers. While such a move would align with Reeves' growth agenda, it would severely limit investor flexibility. From a public policy perspective and for the brokers and fund managers who make a living off the UK markets, the case for refocusing ISAs on UK assets may seem compelling. The UK stock market has struggled as pension funds have dramatically reduced their UK equity holdings since the late 1990s, and retail investors have increasingly favoured US equities. However, from the perspective of ISA investors, such restrictions would be a step backward to the old days of personal equity plans, which had such limitations on overseas investments before they were replaced by ISAs. Limiting stocks and shares ISAs to UK assets – or requiring a minimum level of UK exposure - would reduce the scope for diversification, a cornerstone of sensible investing. Historically, overseas markets —notably US equities — have often outperformed UK equities over long periods. Forcing investors to prioritise UK stocks could undermine the very returns Reeves seeks to enhance. A potential beneficiary of a UK-focused ISA regime could be the investment trust sector, which has faced headwinds recently with trusts trading at wide discounts, limited new share issuance and the arrival of activists on the scene. UK-listed investment trusts that invest globally, many of which are managed in Edinburgh, might attract fresh demand if investors are required to allocate a portion of their ISA to UK-listed assets. Such trusts could offer a workaround, allowing exposure to international markets while supporting the UK financial services sector, a significant tax revenue generator and employer in both London and Edinburgh. An alternative to mandating UK investment in ISAs could be through incentives or the removal of impediments, such as scrapping stamp duty on UK share purchases within ISAs, which undermines the 'tax-free' promise and is a disadvantage over buying US shares where no such transaction tax exists. An even bolder idea would be a modest income tax credit or top-up 'bonus' for stocks and shares ISA subscriptions, subject to a minimum holding period to prevent short-term trading. This could incentivise equity investment while preserving saver choice. As we await the launch of the consultation and its outcome, likely to be detailed in the Autumn Budget, savers and investors would be wise to make use of the current allowances while they can, especially given the high tax burden. The £20,000 ISA allowance is safe for now, but changes to cash ISAs or restrictions on stocks and shares ISAs could reshape how we save and invest in the future. The Chancellor's desire to boost UK investment is laudable, but it must not come at the expense of savers' flexibility or financial security. Jason Hollands is a managing director at wealth management firm Evelyn Partners which has offices in Glasgow, Edinburgh, and Aberdeen